Immunochemical determination of lonidamine in rat tissues and blood serum

G. Citro, R. Galati, A. Verdina, S. Castiglione, B. Silvestrini, A. Caputo, A. Floridi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Lonidamine (LND) is an antitumor drug which interferes selectively with the energy metabolism of neoplastic cell. Because of its physicochemical properties, LND determination with conventional methods, i.e. high performance liquid chromatography and spectrofluorimetry, gives rise to several problems: LND is a lipotropic drug which becomes intimately associated with biological membranes so that it is impossible to extract all the drug bound, thus leading to an underestimation of the LND content in cells and tissues. These difficulties can be overcome by the immunoenzymatic method described here. The assay is simple, rapid, practical, highly sensitive (2-5 ng/ml) and particularly suitable for the analysis of multiple samples (twelve samples in triplicate for each plate). There is, moreover, a great improvement in data reproducibility.

Original languageEnglish
Pages (from-to)811-815
Number of pages5
JournalAnticancer Research
Volume9
Issue number3
Publication statusPublished - 1989

Fingerprint

Serum
Lipotropic Agents
Antineoplastic Agents
Energy Metabolism
High Pressure Liquid Chromatography
Membranes
lonidamine
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Citro, G., Galati, R., Verdina, A., Castiglione, S., Silvestrini, B., Caputo, A., & Floridi, A. (1989). Immunochemical determination of lonidamine in rat tissues and blood serum. Anticancer Research, 9(3), 811-815.

Immunochemical determination of lonidamine in rat tissues and blood serum. / Citro, G.; Galati, R.; Verdina, A.; Castiglione, S.; Silvestrini, B.; Caputo, A.; Floridi, A.

In: Anticancer Research, Vol. 9, No. 3, 1989, p. 811-815.

Research output: Contribution to journalArticle

Citro, G, Galati, R, Verdina, A, Castiglione, S, Silvestrini, B, Caputo, A & Floridi, A 1989, 'Immunochemical determination of lonidamine in rat tissues and blood serum', Anticancer Research, vol. 9, no. 3, pp. 811-815.
Citro G, Galati R, Verdina A, Castiglione S, Silvestrini B, Caputo A et al. Immunochemical determination of lonidamine in rat tissues and blood serum. Anticancer Research. 1989;9(3):811-815.
Citro, G. ; Galati, R. ; Verdina, A. ; Castiglione, S. ; Silvestrini, B. ; Caputo, A. ; Floridi, A. / Immunochemical determination of lonidamine in rat tissues and blood serum. In: Anticancer Research. 1989 ; Vol. 9, No. 3. pp. 811-815.
@article{8ca70df00b574a3aa1f206c39bc7c939,
title = "Immunochemical determination of lonidamine in rat tissues and blood serum",
abstract = "Lonidamine (LND) is an antitumor drug which interferes selectively with the energy metabolism of neoplastic cell. Because of its physicochemical properties, LND determination with conventional methods, i.e. high performance liquid chromatography and spectrofluorimetry, gives rise to several problems: LND is a lipotropic drug which becomes intimately associated with biological membranes so that it is impossible to extract all the drug bound, thus leading to an underestimation of the LND content in cells and tissues. These difficulties can be overcome by the immunoenzymatic method described here. The assay is simple, rapid, practical, highly sensitive (2-5 ng/ml) and particularly suitable for the analysis of multiple samples (twelve samples in triplicate for each plate). There is, moreover, a great improvement in data reproducibility.",
author = "G. Citro and R. Galati and A. Verdina and S. Castiglione and B. Silvestrini and A. Caputo and A. Floridi",
year = "1989",
language = "English",
volume = "9",
pages = "811--815",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - Immunochemical determination of lonidamine in rat tissues and blood serum

AU - Citro, G.

AU - Galati, R.

AU - Verdina, A.

AU - Castiglione, S.

AU - Silvestrini, B.

AU - Caputo, A.

AU - Floridi, A.

PY - 1989

Y1 - 1989

N2 - Lonidamine (LND) is an antitumor drug which interferes selectively with the energy metabolism of neoplastic cell. Because of its physicochemical properties, LND determination with conventional methods, i.e. high performance liquid chromatography and spectrofluorimetry, gives rise to several problems: LND is a lipotropic drug which becomes intimately associated with biological membranes so that it is impossible to extract all the drug bound, thus leading to an underestimation of the LND content in cells and tissues. These difficulties can be overcome by the immunoenzymatic method described here. The assay is simple, rapid, practical, highly sensitive (2-5 ng/ml) and particularly suitable for the analysis of multiple samples (twelve samples in triplicate for each plate). There is, moreover, a great improvement in data reproducibility.

AB - Lonidamine (LND) is an antitumor drug which interferes selectively with the energy metabolism of neoplastic cell. Because of its physicochemical properties, LND determination with conventional methods, i.e. high performance liquid chromatography and spectrofluorimetry, gives rise to several problems: LND is a lipotropic drug which becomes intimately associated with biological membranes so that it is impossible to extract all the drug bound, thus leading to an underestimation of the LND content in cells and tissues. These difficulties can be overcome by the immunoenzymatic method described here. The assay is simple, rapid, practical, highly sensitive (2-5 ng/ml) and particularly suitable for the analysis of multiple samples (twelve samples in triplicate for each plate). There is, moreover, a great improvement in data reproducibility.

UR - http://www.scopus.com/inward/record.url?scp=0024342373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024342373&partnerID=8YFLogxK

M3 - Article

C2 - 2669622

AN - SCOPUS:0024342373

VL - 9

SP - 811

EP - 815

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3

ER -